Pardes Biosciences Performance
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
The company holds a Beta of 0.54, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pardes Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pardes Biosciences is expected to be smaller as well. Pardes Biosciences right now holds a risk of 0.0%. Please check Pardes Biosciences potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Pardes Biosciences will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 268.7 M | |
| Total Cashflows From Investing Activities | -137 M |
Pardes |
Pardes Biosciences Relative Risk vs. Return Landscape
If you would invest 214.00 in Pardes Biosciences on July 19, 2024 and sell it today you would earn a total of 0.00 from holding Pardes Biosciences or generate 0.0% return on investment over 90 days. Pardes Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Pardes, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pardes Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pardes Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pardes Biosciences, and traders can use it to determine the average amount a Pardes Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PRDS |
Based on monthly moving average Pardes Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pardes Biosciences by adding Pardes Biosciences to a well-diversified portfolio.
Pardes Biosciences Fundamentals Growth
Pardes Stock prices reflect investors' perceptions of the future prospects and financial health of Pardes Biosciences, and Pardes Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pardes Stock performance.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Cash And Equivalents | 228.6 M | |||
| Cash Per Share | 3.67 X | |||
| Book Value Per Share | 2.57 X | |||
| Cash Flow From Operations | (71.98 M) | |||
| Earnings Per Share | (1.28) X | |||
| Total Asset | 200.62 M | |||
| Retained Earnings | (148.16 M) | |||
About Pardes Biosciences Performance
Assessing Pardes Biosciences' fundamental ratios provides investors with valuable insights into Pardes Biosciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pardes Biosciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. The company was incorporated in 2020 and is headquartered in Carlsbad, California. Pardes Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.Things to note about Pardes Biosciences performance evaluation
Checking the ongoing alerts about Pardes Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pardes Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pardes Biosciences is not yet fully synchronised with the market data | |
| Pardes Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pardes Biosciences currently holds about 228.6 M in cash with (71.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
- Analyzing Pardes Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pardes Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Pardes Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pardes Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pardes Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pardes Biosciences' stock. These opinions can provide insight into Pardes Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |